Table 4.
Model 1 (n=1529) | Model 2 (n=880)* | |||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
QRS-T angle >90° | 1.8 (1.34–2.30) | <0.0001 | 2.2 (1.59–3.10) | <0.0001 |
Age | 1.0 (0.99–1.01) | 0.47 | 1.0 (1.00–1.02) | 0.12 |
Male gender | 1.1 (0.86–1.38) | 0.47 | 1.0 (0.71–1.32) | 0.83 |
Heart rate | 1.0 (1.03–1.04) | <0.0001 | 1.0 (1.01–1.03) | <0.0001 |
Prolonged intraventricular conduction | 1.0 (0.78–1.40) | 0.78 | 1.1 (0.74–1.56) | 0.69 |
Hypertension | 1.2 (0.94–1.54) | 0.14 | 1.1 (0.78–1.60) | 0.54 |
Diabetes mellitus | 1.6 (1.25–2.00) | 0.0001 | 1.8 (1.30–2.38) | 0.0002 |
Previous MI | 1.1 (0.86–1.36) | 0.49 | 1.2 (0.90–1.62) | 0.22 |
ECG LVH | 1.2 (0.86–1.66) | 0.28 | 1.0 (0.67–1.50) | 0.99 |
Severely impaired LVEF† | - | - | 1.6 (1.09–2.46) | 0.02 |
LVEF denotes left ventricular ejection fraction; MI, myocardial infarction; LVH by ECG, left ventricular hypertrophy by electrocardiographic criteria
Prolonged intraventricular conduction defined as QRS duration (QRSD) >110ms; Severely impaired LVEF, ≤35%.
For Model 2, results were calculated using the non-missing data as the denominator.
Information on LVEF was available for 330 cases and 402 controls.